SCHEMBL8963453

SCHEMBL8963453

CCCCc1[nH]c(-c2ccc(C)cc2)nc1CN1CCN(C(c2ccccc2)c2ccccc2)CC1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.52
CYP2C19 P33261 2/20 0.52
CYP2C9 P11712 1/20 0.52
DRD2 P14416 2/20 0.42
DRD4 P21917 2/20 0.42
DRD3 P35462 2/20 0.42
NPSR1 Q6W5P4 3/20 0.41
LMNA P02545 3/20 0.41
HTT P42858 2/20 0.41
P2RX7 Q99572 5/20 0.40
ALDH1A1 P00352 2/20 0.40
USP2 O75604 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
HPN P05981 1/20 0.40
CHRM2 P08172 1/20 0.40
ADRA2A P08913 1/20 0.40
ADORA3 P0DMS8 1/20 0.40
CHRM1 P11229 1/20 0.40
ADRA2C P18825 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8963681 0.95 CYP3A4 (0.53) CYP3A4CYP2C19CYP2C9DRD2DRD4
Lifarizine SCHEMBL676318 0.85 DRD2 (0.57) CYP3A4CYP2C19CYP2C9DRD2DRD4
Lifarizine SCHEMBL8963776 0.84 DRD2 (0.56) CYP3A4CYP2C19CYP2C9DRD2DRD4
SCHEMBL8963806 0.84 CYP3A4 (0.56) CYP3A4CYP2C19CYP2C9DRD2DRD4
Lifarizine SCHEMBL14809613 0.83 CYP3A4 (0.57) CYP3A4CYP2C19CYP2C9DRD2DRD4
Lifarizine SCHEMBL94691 0.83 CYP3A4 (0.57) CYP3A4CYP2C19CYP2C9DRD2DRD4
Lifarizine SCHEMBL2231142 0.82 CYP3A4 (0.56) CYP3A4CYP2C19CYP2C9DRD2DRD4
SCHEMBL8963815 0.82 CYP3A4 (0.53) CYP3A4CYP2C19CYP2C9DRD2DRD4
SCHEMBL9424741 0.81 DRD3 (0.55) CYP3A4CYP2C19CYP2C9DRD2DRD4
SCHEMBL8963668 0.80 DRD2 (0.64) CYP3A4CYP2C19CYP2C9DRD2DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5514800-A CALCIUM CHANNEL BLOCKERS, CEREBRAL ISCHEMIA SYNTEX PHARMACEUTICALS, LTD. (GB) 1996-05-07 US disclosed
US-5276034-A Cardiovascular disorders, nervous system disorders, diuretics, antiischemic agents or antispasmodic agents SYNTEX PHARMACEUTICAL LTD. (GB) 1994-01-04 US disclosed
US-5043447-A Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives SYNTEX PHARMACEUTICALS, LTD. (GB) 1991-08-27 US disclosed